Figure 4
From: The Role of Macrophage Migration Inhibitory Factor in Alzheimer’s Disease
(A) Detection of MIF in CSF of AD patients (n = 7) and age-/gender-matched controls (n = 7). (B) MIF-ELISA with lysed brain tissues collected from AD patients (n = 10) and healthy individuals as control (n = 9). We performed a Mann—Whitney U test for nonparametric distributed values to test group differences in MIF concentrations and found significantly elevated MIF levels (P < 0.001) in AD patients in comparison to healthy controls (A).